The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA
The inhibition of gene expression by RNA interference harbors a high potential for application in the therapy of human diseases. However, while exogenous application of siRNAs efficiently inhibits gene expression, these effects are only transient in mammalian cells. We designed a short hairpin RNA-e...
Gespeichert in:
Veröffentlicht in: | Human gene therapy 2005-04, Vol.16 (4), p.533-539 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 539 |
---|---|
container_issue | 4 |
container_start_page | 533 |
container_title | Human gene therapy |
container_volume | 16 |
creator | JENKE, Andreas C. W EISENBERGER, Tobias BAIKER, Armin STEHLE, Isa M WIRTH, Stefan LIPPS, Hans Joachim |
description | The inhibition of gene expression by RNA interference harbors a high potential for application in the therapy of human diseases. However, while exogenous application of siRNAs efficiently inhibits gene expression, these effects are only transient in mammalian cells. We designed a short hairpin RNA-expression cassette to target the bcr-abl oncogene that was then introduced into the nonviral vector system pEPI-1, which replicates episomally in the absence of selection in the bcr-abl-positive cell line K562. Forty-two days after transfection the bcr-abl- but not the cytokine-dependent growth rate was found to be drastically reduced in K562 cells. Western analysis revealed a more than 90% reduction in the expression of the fusion protein bcr-abl while the expression of the bcr protein remained unaffected. In addition, we show that the level of bcr-abl mRNA was specifically reduced in these cells for more than 90%. These results demonstrate that the vector system pEPI-1 allows specific and efficient long term gene suppression by using a short hairpin RNA transcription unit. |
doi_str_mv | 10.1089/hum.2005.16.533 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67805794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17864936</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-54365f9e240ecdef6e5243f405a3facd7979ee2b257a6f9567c00e2403028fe33</originalsourceid><addsrcrecordid>eNqFkb1PHDEQxa0oUSAkdTrkJun28Le9JUKQICGIIlJbXt-YM_KuF3uPj_8-PnESJdU8jX7zNDMPoe-UrCgx_clmO64YIXJF1Upy_gEdUil1pwVjH5smgneEC3aAvtR6TwjlUunP6IBKo6ky8hDd324AT3l6jMUlDHOseWyiwJyid0uc7vAj-CUXPJ__uewodinlp4pTnu66BcqI47SJQ1xinnAOePClc0Nzep4L1LrrDi-4bv5en35Fn4JLFb7t6xH6d3F-e_a7u7r5dXl2etX5tt3SScGVDD0wQcCvISiQTPAgiHQ8OL_Wve4B2MCkdir07SBPyI7mhJkAnB-hn6--c8kPW6iLHWP1kJKbIG-rVdoQqXvxLki1UaLnqoEnr6AvudYCwc4ljq68WErsLgfbcrC7HCxVtuXQJo731tthhPUbv398A37sAVe9S6G4ycf6xiktjTGM_wfQqpEG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17864936</pqid></control><display><type>article</type><title>The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA</title><source>Mary Ann Liebert Online Subscription</source><source>MEDLINE</source><creator>JENKE, Andreas C. W ; EISENBERGER, Tobias ; BAIKER, Armin ; STEHLE, Isa M ; WIRTH, Stefan ; LIPPS, Hans Joachim</creator><creatorcontrib>JENKE, Andreas C. W ; EISENBERGER, Tobias ; BAIKER, Armin ; STEHLE, Isa M ; WIRTH, Stefan ; LIPPS, Hans Joachim</creatorcontrib><description>The inhibition of gene expression by RNA interference harbors a high potential for application in the therapy of human diseases. However, while exogenous application of siRNAs efficiently inhibits gene expression, these effects are only transient in mammalian cells. We designed a short hairpin RNA-expression cassette to target the bcr-abl oncogene that was then introduced into the nonviral vector system pEPI-1, which replicates episomally in the absence of selection in the bcr-abl-positive cell line K562. Forty-two days after transfection the bcr-abl- but not the cytokine-dependent growth rate was found to be drastically reduced in K562 cells. Western analysis revealed a more than 90% reduction in the expression of the fusion protein bcr-abl while the expression of the bcr protein remained unaffected. In addition, we show that the level of bcr-abl mRNA was specifically reduced in these cells for more than 90%. These results demonstrate that the vector system pEPI-1 allows specific and efficient long term gene suppression by using a short hairpin RNA transcription unit.</description><identifier>ISSN: 1043-0342</identifier><identifier>EISSN: 1557-7422</identifier><identifier>DOI: 10.1089/hum.2005.16.533</identifier><identifier>PMID: 15871685</identifier><identifier>CODEN: HGTHE3</identifier><language>eng</language><publisher>Larchmont, NY: Liebert</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Applied cell therapy and gene therapy ; Base Sequence ; Biological and medical sciences ; Biotechnology ; Blotting, Northern ; Blotting, Western ; Cell Proliferation ; Cytokines - metabolism ; DNA Polymerase III - genetics ; Fundamental and applied biological sciences. Psychology ; Fusion Proteins, bcr-abl - drug effects ; Fusion Proteins, bcr-abl - genetics ; Gene Expression Regulation - drug effects ; Gene therapy ; Genetic Vectors - genetics ; Genetic Vectors - pharmacology ; Health. Pharmaceutical industry ; Humans ; Industrial applications and implications. Economical aspects ; K562 Cells ; Medical sciences ; Molecular Sequence Data ; Plasmids - genetics ; Promoter Regions, Genetic ; RNA - chemistry ; RNA - genetics ; RNA - pharmacology ; RNA, Catalytic - chemistry ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Virus Replication - genetics</subject><ispartof>Human gene therapy, 2005-04, Vol.16 (4), p.533-539</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-54365f9e240ecdef6e5243f405a3facd7979ee2b257a6f9567c00e2403028fe33</citedby><cites>FETCH-LOGICAL-c356t-54365f9e240ecdef6e5243f405a3facd7979ee2b257a6f9567c00e2403028fe33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,3029,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16758882$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15871685$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JENKE, Andreas C. W</creatorcontrib><creatorcontrib>EISENBERGER, Tobias</creatorcontrib><creatorcontrib>BAIKER, Armin</creatorcontrib><creatorcontrib>STEHLE, Isa M</creatorcontrib><creatorcontrib>WIRTH, Stefan</creatorcontrib><creatorcontrib>LIPPS, Hans Joachim</creatorcontrib><title>The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA</title><title>Human gene therapy</title><addtitle>Hum Gene Ther</addtitle><description>The inhibition of gene expression by RNA interference harbors a high potential for application in the therapy of human diseases. However, while exogenous application of siRNAs efficiently inhibits gene expression, these effects are only transient in mammalian cells. We designed a short hairpin RNA-expression cassette to target the bcr-abl oncogene that was then introduced into the nonviral vector system pEPI-1, which replicates episomally in the absence of selection in the bcr-abl-positive cell line K562. Forty-two days after transfection the bcr-abl- but not the cytokine-dependent growth rate was found to be drastically reduced in K562 cells. Western analysis revealed a more than 90% reduction in the expression of the fusion protein bcr-abl while the expression of the bcr protein remained unaffected. In addition, we show that the level of bcr-abl mRNA was specifically reduced in these cells for more than 90%. These results demonstrate that the vector system pEPI-1 allows specific and efficient long term gene suppression by using a short hairpin RNA transcription unit.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Applied cell therapy and gene therapy</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Blotting, Northern</subject><subject>Blotting, Western</subject><subject>Cell Proliferation</subject><subject>Cytokines - metabolism</subject><subject>DNA Polymerase III - genetics</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fusion Proteins, bcr-abl - drug effects</subject><subject>Fusion Proteins, bcr-abl - genetics</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Gene therapy</subject><subject>Genetic Vectors - genetics</subject><subject>Genetic Vectors - pharmacology</subject><subject>Health. Pharmaceutical industry</subject><subject>Humans</subject><subject>Industrial applications and implications. Economical aspects</subject><subject>K562 Cells</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Plasmids - genetics</subject><subject>Promoter Regions, Genetic</subject><subject>RNA - chemistry</subject><subject>RNA - genetics</subject><subject>RNA - pharmacology</subject><subject>RNA, Catalytic - chemistry</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Virus Replication - genetics</subject><issn>1043-0342</issn><issn>1557-7422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkb1PHDEQxa0oUSAkdTrkJun28Le9JUKQICGIIlJbXt-YM_KuF3uPj_8-PnESJdU8jX7zNDMPoe-UrCgx_clmO64YIXJF1Upy_gEdUil1pwVjH5smgneEC3aAvtR6TwjlUunP6IBKo6ky8hDd324AT3l6jMUlDHOseWyiwJyid0uc7vAj-CUXPJ__uewodinlp4pTnu66BcqI47SJQ1xinnAOePClc0Nzep4L1LrrDi-4bv5en35Fn4JLFb7t6xH6d3F-e_a7u7r5dXl2etX5tt3SScGVDD0wQcCvISiQTPAgiHQ8OL_Wve4B2MCkdir07SBPyI7mhJkAnB-hn6--c8kPW6iLHWP1kJKbIG-rVdoQqXvxLki1UaLnqoEnr6AvudYCwc4ljq68WErsLgfbcrC7HCxVtuXQJo731tthhPUbv398A37sAVe9S6G4ycf6xiktjTGM_wfQqpEG</recordid><startdate>20050401</startdate><enddate>20050401</enddate><creator>JENKE, Andreas C. W</creator><creator>EISENBERGER, Tobias</creator><creator>BAIKER, Armin</creator><creator>STEHLE, Isa M</creator><creator>WIRTH, Stefan</creator><creator>LIPPS, Hans Joachim</creator><general>Liebert</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050401</creationdate><title>The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA</title><author>JENKE, Andreas C. W ; EISENBERGER, Tobias ; BAIKER, Armin ; STEHLE, Isa M ; WIRTH, Stefan ; LIPPS, Hans Joachim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-54365f9e240ecdef6e5243f405a3facd7979ee2b257a6f9567c00e2403028fe33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Applied cell therapy and gene therapy</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Blotting, Northern</topic><topic>Blotting, Western</topic><topic>Cell Proliferation</topic><topic>Cytokines - metabolism</topic><topic>DNA Polymerase III - genetics</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fusion Proteins, bcr-abl - drug effects</topic><topic>Fusion Proteins, bcr-abl - genetics</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Gene therapy</topic><topic>Genetic Vectors - genetics</topic><topic>Genetic Vectors - pharmacology</topic><topic>Health. Pharmaceutical industry</topic><topic>Humans</topic><topic>Industrial applications and implications. Economical aspects</topic><topic>K562 Cells</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Plasmids - genetics</topic><topic>Promoter Regions, Genetic</topic><topic>RNA - chemistry</topic><topic>RNA - genetics</topic><topic>RNA - pharmacology</topic><topic>RNA, Catalytic - chemistry</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Virus Replication - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JENKE, Andreas C. W</creatorcontrib><creatorcontrib>EISENBERGER, Tobias</creatorcontrib><creatorcontrib>BAIKER, Armin</creatorcontrib><creatorcontrib>STEHLE, Isa M</creatorcontrib><creatorcontrib>WIRTH, Stefan</creatorcontrib><creatorcontrib>LIPPS, Hans Joachim</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Human gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JENKE, Andreas C. W</au><au>EISENBERGER, Tobias</au><au>BAIKER, Armin</au><au>STEHLE, Isa M</au><au>WIRTH, Stefan</au><au>LIPPS, Hans Joachim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA</atitle><jtitle>Human gene therapy</jtitle><addtitle>Hum Gene Ther</addtitle><date>2005-04-01</date><risdate>2005</risdate><volume>16</volume><issue>4</issue><spage>533</spage><epage>539</epage><pages>533-539</pages><issn>1043-0342</issn><eissn>1557-7422</eissn><coden>HGTHE3</coden><abstract>The inhibition of gene expression by RNA interference harbors a high potential for application in the therapy of human diseases. However, while exogenous application of siRNAs efficiently inhibits gene expression, these effects are only transient in mammalian cells. We designed a short hairpin RNA-expression cassette to target the bcr-abl oncogene that was then introduced into the nonviral vector system pEPI-1, which replicates episomally in the absence of selection in the bcr-abl-positive cell line K562. Forty-two days after transfection the bcr-abl- but not the cytokine-dependent growth rate was found to be drastically reduced in K562 cells. Western analysis revealed a more than 90% reduction in the expression of the fusion protein bcr-abl while the expression of the bcr protein remained unaffected. In addition, we show that the level of bcr-abl mRNA was specifically reduced in these cells for more than 90%. These results demonstrate that the vector system pEPI-1 allows specific and efficient long term gene suppression by using a short hairpin RNA transcription unit.</abstract><cop>Larchmont, NY</cop><pub>Liebert</pub><pmid>15871685</pmid><doi>10.1089/hum.2005.16.533</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1043-0342 |
ispartof | Human gene therapy, 2005-04, Vol.16 (4), p.533-539 |
issn | 1043-0342 1557-7422 |
language | eng |
recordid | cdi_proquest_miscellaneous_67805794 |
source | Mary Ann Liebert Online Subscription; MEDLINE |
subjects | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Applied cell therapy and gene therapy Base Sequence Biological and medical sciences Biotechnology Blotting, Northern Blotting, Western Cell Proliferation Cytokines - metabolism DNA Polymerase III - genetics Fundamental and applied biological sciences. Psychology Fusion Proteins, bcr-abl - drug effects Fusion Proteins, bcr-abl - genetics Gene Expression Regulation - drug effects Gene therapy Genetic Vectors - genetics Genetic Vectors - pharmacology Health. Pharmaceutical industry Humans Industrial applications and implications. Economical aspects K562 Cells Medical sciences Molecular Sequence Data Plasmids - genetics Promoter Regions, Genetic RNA - chemistry RNA - genetics RNA - pharmacology RNA, Catalytic - chemistry Transfusions. Complications. Transfusion reactions. Cell and gene therapy Virus Replication - genetics |
title | The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T06%3A27%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20nonviral%20episomal%20replicating%20vector%20pEPI-1%20allows%20long-term%20inhibition%20of%20bcr-abl%20expression%20by%20shRNA&rft.jtitle=Human%20gene%20therapy&rft.au=JENKE,%20Andreas%20C.%20W&rft.date=2005-04-01&rft.volume=16&rft.issue=4&rft.spage=533&rft.epage=539&rft.pages=533-539&rft.issn=1043-0342&rft.eissn=1557-7422&rft.coden=HGTHE3&rft_id=info:doi/10.1089/hum.2005.16.533&rft_dat=%3Cproquest_cross%3E17864936%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17864936&rft_id=info:pmid/15871685&rfr_iscdi=true |